Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 503.3B, Johnson & Johnson(JNJ) trades at $206.34. The stock has a price-to-earnings ratio of 19.89 and currently yields dividends of 2.5%.
On 2025-11-26, Johnson & Johnson(JNJ) stock traded between a low of $206.34 and a high of $207.20. Shares are currently priced at $206.34, which is 0.0% above the low and -0.4% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 7.17K, against a daily average of 11.56M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $207.72 and a 52-week low of $140.68.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $207.72 and a 52-week low of $140.68.
JNJ News
Johnson & Johnson recently announced that new Phase 3b APEX study data presented at the Inflammatory Skin Disease Summit 2025 showed TREMFYA® continued to reduc...
On Friday, Johnson & Johnson (NYSE:JNJ) said that the Phase 2b AuTonomy proof-of-concept study of posdinemab did not achieve statistical significance in slowing...
Johnson & Johnson (Symbol: JNJ) has been named as a Top 25 ''Dividend Giant'' by ETF Channel , with a staggering $73.76B worth of stock held by ETFs, and above-...
Analyst ratings
59%
of 27 ratingsMore JNJ News
Johnson & Johnson’s JNJ stock has risen 16.7% in the past three months. A lot of this price increase is due to strong third-quarter 2025 results, where in both...
In recent trading, shares of Johnson & Johnson (Symbol: JNJ) have crossed above the average analyst 12-month target price of $175.77, changing hands for $176.64...
Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our P/B Growth Investor mod...
Looking at the universe of stocks we cover at Dividend Channel, on 11/25/25, Vertiv Holdings Co (Symbol: VRT), Primo Brands Corp (Symbol: PRMB), and Johnson & J...
This week's dividend activity included increased payouts from Merck (MRK) and Nike (NKE) as well as declarations from companies such as Nvidia (NVDA) and Home D...
Wondering if Johnson & Johnson’s stock could actually be worth more than what the market is pricing in? You’re not alone. Today we’ll take a friendly but forens...
The Food and Drug Administration announced traditional approval of Johnson & Johnson’s Darzalex Faspro with bortezomib, cyclophosphamide, and dexamethasone for...